Tesaglitazar ameliorates non-alcoholic fatty liver disease and atherosclerosis development in diabetic low-density lipoprotein receptor-deficient mice

類似資料

• Salidroside Decreases Atherosclerotic Plaque Formation in Low-Density Lipoprotein Receptor-Deficient Mice
  著者:: Zhang, Bu-Chun, 等
  出版事項: (2012)
• Tesaglitazar, a dual peroxisome proliferator-activated receptor alpha/gamma agonist, reduces atherosclerosis in female low density lipoprotein receptor deficient mice
  著者:: Chira, Ebele C., 等
  出版事項: (2007)
• Myricetin ameliorates atherosclerosis in the low-density-lipoprotein receptor knockout mice by suppression of cholesterol accumulation in macrophage foam cells
  著者:: Zhe Meng, 等
  出版事項: (2019-04-01)
• Myricetin ameliorates atherosclerosis in the low-density-lipoprotein receptor knockout mice by suppression of cholesterol accumulation in macrophage foam cells
  著者:: Meng, Zhe, 等
  出版事項: (2019)
• Folic acid delays development of atherosclerosis in low‐density lipoprotein receptor‐deficient mice
  著者:: Pan, Sunlei, 等
  出版事項: (2018)